#InterSpinous Spacer

[mrunalnerkarblog]

Interspinous spacers, also known as interspinous process decompression systems, are devices implanted between vertebral spinous processes.

[stevenwilliam12]

Rising Demand for Cancer Cachexia Treatments: Market Insights and Forecasts Through 2032

Cancer cachexia is a complex syndrome characterized by severe weight loss, muscle wasting, and a decline in physical function, significantly impacting the quality of life for cancer patients, particularly in advanced stages. This condition complicates cancer treatment efficacy, highlighting the urgent need for effective therapeutic options, which are currently limited.

Market Overview for Cancer Cachexia

The market for cancer cachexia is poised for significant growth by 2032, driven by the global rise in cancer incidence and the increasing recognition of cachexia as a serious medical condition. As cancer rates continue to rise, so does the prevalence of cancer cachexia, creating a critical area of unmet medical need within oncology.

Key Players in the Cancer Cachexia Market

Several companies are actively engaged in developing therapies for cancer cachexia, including:

AEterna Zentaris

Aphios Corporation

Artelo BIOSCIENCES

Caelus Health

Cannabics Pharmaceuticals

Helsinn Therapeutics

Ildong Pharmaceutical

Incyte Corporation

Janssen Pharmaceutical

NGM Biopharmaceuticals

Ono Pharmaceutical

PsiOxus Therapeutics

Smartfish AS

Tetra Biopharma

Epidemiology of Cancer Cachexia

Cancer cachexia is notably prevalent among patients with advanced-stage cancers, such as pancreatic, lung, and gastrointestinal cancers. According to DelveInsight's analysis, approximately 30-50% of cancer patients experience some degree of cachexia, with the highest rates observed in patients with aggressive malignancies. In the 7MM (United States, EU4, and Japan), over 1.5 million diagnosed prevalent cases of cancer cachexia were estimated in 2023. The incidence of this condition is expected to rise over the next decade due to factors such as aging populations and increasing cancer prevalence.

Competitive Landscape

Despite the competitive nature of the cancer cachexia market, it remains underdeveloped regarding available treatments. Leading pharmaceutical companies are exploring various therapeutic strategies, including appetite stimulants, anti-inflammatory drugs, and anabolic agents. Although advancements in research are being made, no universally effective treatment for all patients has been established. Several therapies are in the pipeline, focusing on novel combinations of medications that aim to alleviate both the symptoms and underlying causes of cancer cachexia.

Market Forecast

The cancer cachexia market is projected to expand rapidly by 2032. A growing understanding of the syndrome's impact on cancer progression and patient outcomes is anticipated to drive market growth. Additionally, regulatory authorities are increasingly fast-tracking the approval of promising treatments, which will facilitate the entry of more drug candidates into clinical trials, significantly enhancing the market's size and scope.

Conclusion

In conclusion, the cancer cachexia treatment market remains a vital area for therapeutic intervention, with substantial growth potential expected in the coming decade. The need for effective treatments and the ongoing research efforts in this field underscore its importance in improving the quality of life for cancer patients.

Latest Reports Offered By DeveInsight:

Vascular Graft Devices Market | Vascular Stents Market | Extracorporeal Membrane Oxygenation Devices Market | Fallopian Tube Cancer Market | Physiotherapy Equipment Market | Postoperative Nausea And Vomiting Market | Relapsing Multiple Sclerosis Market | Respiratory Distress Syndrome Market | Interspinous Spacers Market | Resorbable Vascular Scaffold Market | Smart Inhalers Market | Diverticulosis Market | Fenebrutinib Market | Indolent Lymphoma Market | Optic Neuropathy Market | Tbi Market | Trastuzumab Market | Urinary Incontinence Market | Cytomegalovirus Infections Market | Dense Deposit Disease Market | Diabetic Eye Disease Market | Gestational Diabetes Market | Panuveitis Market | Type 2 Diabetes Market | Advanced Wound Care Market

[insightsresearch]

Interspinous Spacers Market Analysis, Business Outlook for 2024-2036

Interspinous Spacers Market Analysis, Business Outlook for 2024-2036 The Interspinous Spacers Market report provides a comprehensive analysis of the current state and future prospects of the Interspinous Spacers Market. This report aims to provide key insights and valuable information to industry stakeholders, investors, and decision-makers. By examining the market dynamics, trends, challenges, and opportunities, this report offers a holistic view of the Interspinous Spacers Market. Purpose of the Report The purpose of this report is to analyze the Interspinous Spacers Market and provide actionable intelligence to help businesses and organizations make informed decisions. It aims to provide a detailed understanding of the market landscape, competitive scenario, and growth potential. Scope of the Report The report covers various aspects of the Interspinous Spacers Market, including market size, growth rate, key players, market segmentation, and industry trends. It also includes an in-depth analysis of the competitive landscape, market dynamics, and regulatory framework. Size of the Interspinous Spacers Market Interspinous Spacers Market size was over USD 75.26 Million in 2023 and is anticipated to reach USD 160.52 Million by the end of 2036, witnessing around 6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of interspinous spacers is assessed at USD 79.78 Million. Key Players ·       Spinal Simplicity ·       Life Spine, Inc. ·       NuVasive, Inc. ·       Medtronic plc Emerging Trends ·       The report identifies a growing trend of Interspinous Spacers companies adopting innovative technologies. ·       This includes the implementation of AI and automation in Interspinous Spacers processes. Key Findings The Interspinous Spacers Market report provides a comprehensive analysis of the market's current state and future prospects. The key findings from the report highlight the market's potential for growth and the numerous opportunities it presents for businesses and investors. 1.      Market Potential: The Interspinous Spacers Market is projected to experience significant growth in the coming years. The report identifies several factors driving this growth, including increasing consumer demand, technological advancements, and favorable government policies. 2.      Segment Analysis: The report includes a detailed analysis of different segments within the Interspinous Spacers Market. It provides insights into the market size, growth rate, and key trends in each segment. This information can help businesses identify lucrative opportunities and tailor their strategies accordingly. 3.      Regional Analysis: The report also examines the Interspinous Spacers Market on a regional level, providing insights into the market dynamics and trends in different geographic areas. This analysis can help businesses understand the regional variations in consumer preferences and behavior, enabling them to target specific markets effectively. 4.      Competitive Landscape: The report assesses the competitive landscape of the Interspinous Spacers Market, profiling key players and analyzing their strategies. It provides valuable insights into the market's competitive intensity, helping businesses identify their strengths and weaknesses and develop effective competitive strategies.   Future Outlook ·       The Interspinous Spacers Market is expected to witness robust growth in the coming years, driven by factors such as increasing urbanization, rising disposable incomes, and changing consumer preferences. ·       However, companies need to navigate challenges such as intense competition, regulatory uncertainties, and evolving customer expectations. ·       By staying agile, embracing digital transformation, and fostering innovation, businesses can position themselves for success in the dynamic Interspinous Spacers Market. Source: https://www.researchnester.com/reports/interspinous-spacers-market/4445

[kayvanh123]

What is Vertiflex?

Vertiflex is a minimally invasive treatment option designed to relieve chronic pain associated with lumbar spinal stenosis (LSS). Lumbar spinal stenosis is a condition where the spinal canal narrows, causing pressure on the spinal cord and nerves, leading to pain, numbness, and weakness in the lower back and legs.

What is Vertiflex?

The Vertiflex Procedure, also known as the Vertiflex Superion Interspinous Spacer, involves the placement of a small implant between the spinous processes (the bony projections on the back of the vertebrae) in the lumbar spine. This device is designed to create space and reduce pressure on the affected nerves.

How Does Vertiflex Help Chronic Pain?

Decompression of Nerves:

The Vertiflex device works by lifting and separating the vertebrae, which helps to widen the spinal canal and reduce the compression of nerves. This decompression alleviates the symptoms of pain, numbness, and tingling associated with LSS.

Minimally Invasive:

The procedure is performed through a small incision, typically requiring only local anesthesia and sedation. This minimally invasive approach reduces the risk of complications and promotes faster recovery compared to traditional open spine surgery.

Stability:

Unlike some other treatments that may involve removing bone or tissue, the Vertiflex device maintains the stability of the spine while providing the necessary space for the nerves.

Preservation of Motion:

The Vertiflex implant preserves the natural movement of the spine, allowing patients to maintain their range of motion and flexibility.

Outpatient Procedure:

The Vertiflex procedure can often be performed on an outpatient basis, meaning patients can go home the same day. This convenience reduces the overall disruption to patients’ lives and allows for a quicker return to normal activities.

Benefits of Vertiflex

Effective Pain Relief: Clinical studies have shown that the Vertiflex Procedure can significantly reduce pain and improve function in patients with lumbar spinal stenosis.

Minimized Risks: Because the procedure is minimally invasive, there is a lower risk of infection, blood loss, and other complications compared to traditional spine surgery.

Quick Recovery: Patients typically experience a shorter recovery time and less postoperative pain, enabling them to resume their daily activities sooner.

Long-Lasting Results: Many patients report sustained pain relief and improved quality of life following the Vertiflex Procedure.

Who is a Candidate for Vertiflex?

The Vertiflex Procedure is generally recommended for patients who:

Have been diagnosed with moderate to severe lumbar spinal stenosis.

Experience significant pain and disability that impacts their daily life.

Have not found adequate relief from conservative treatments such as physical therapy, medications, or epidural injections.

Are not candidates for, or prefer to avoid, traditional open spine surgery.

For more information about our clinic, medical professionals, and treatment options, please visit our main website.

[nidarsanafwr]

https://community.wongcw.com/blogs/721946/Interspinous-Spacers-Market-Size-Overview-Share-and-Forecast-2031

Interspinous Spacers Market Size, Overview, Share and Forecast 2031

[srilatha]

Interspinous Spacers Market Overview

The Interspinous Spacers Market size is forecast to reach $117.4 million by 2027 and is expected to grow at a CAGR of 4.9% during the forecast period 2022-2027. Interspinous spacers, also knowns as Interspinous Process Decompression systems (IPD), are small implant devices that are inserted into the back of a spine for the treatment of Spinal ailments such as Spinal Canal Stenosis and Degenerative Disc Diseases. The Spacers create more space for the spinal cord and nerves in the spinal columns without the removal of any bone. This in turn minimizes trauma to the muscles and ligaments. The Interspinous Spacers Market has been driven by advances made in the field of minimal invasive surgeries. Moreover, the increasing number of geriatric populations worldwide has led to rising cases of spinal diseases such as Arthritis, which has further pushed the demand for Interspinous Spacers.

https://www.industryarc.com/Research/interspinous-spacers-market-research-511276?utm_source=sbm&utm_medium=refferal&utm_campaign=srilatha

[healthcare-23]

Spinal Stenosis Surgery: An In-Depth Overview

Spinal stenosis is a debilitating condition characterized by the narrowing of the spinal canal, resulting in the compression of spinal nerves and the spinal cord. When conservative treatments fail to provide relief, spinal stenosis surgery becomes a viable option. This article aims to provide a comprehensive overview of spinal stenosis surgery, including its indications, different surgical approaches, and associated risks and benefits.

I. Understanding Spinal Stenosis

Spinal stenosis is primarily caused by age-related degenerative changes in the spine, such as osteoarthritis, bone spurs, herniated discs, or thickened ligaments. These changes gradually reduce the space within the spinal canal, leading to the compression of neural structures. Patients typically experience symptoms like pain, numbness, weakness, and difficulty walking or maintaining balance.

II. Indications for Surgery

Spinal stenosis surgery is usually considered when conservative treatments like physical therapy, pain medication, and epidural injections fail to alleviate symptoms adequately. The decision to proceed with surgery is made based on the severity of symptoms, the impact on daily activities, and the presence of neurological deficits.

III. Surgical Approaches for Spinal Stenosis

A. Decompressive laminectomy: This procedure involves the removal of a portion of the lamina, the bony arch covering the spinal canal, to create more space for the compressed nerves. It is the most common surgical intervention for spinal stenosis.

B. Laminotomy: In this procedure, only a small portion of the lamina is removed to relieve pressure on the affected nerves, offering a more targeted approach compared to laminectomy.

C. Foraminotomy: This surgery involves enlarging the neural foramen, the passageway through which the nerve roots exit the spinal canal, to alleviate nerve compression.

D. Spinal fusion: In cases where spinal instability is present, spinal fusion may be performed along with decompression. It involves fusing two or more vertebrae together using bone grafts or implants to provide stability.

E. Interspinous process spacer: This minimally invasive procedure involves inserting a spacer between the spinous processes to maintain the space within the spinal canal and alleviate symptoms.

IV. Risks and Benefits of Surgery

A. Risks:

  1. Infection: There is a risk of infection at the surgical site, requiring antibiotics or further interventions.

  2. Bleeding: Excessive bleeding during or after surgery may necessitate a blood transfusion or additional procedures.

  3. Nerve damage: Surgical interventions near the spinal nerves carry a risk of nerve damage, resulting in sensory or motor deficits.

  4. Blood clots: Prolonged immobility during and after surgery increases the risk of blood clots forming in the legs or lungs.

  5. Failed back surgery syndrome: In some cases, surgery may not provide the desired relief, leading to persistent or recurrent symptoms.

B. Benefits:

  1. Symptom relief: Surgery aims to alleviate pain, numbness, and weakness, allowing patients to regain mobility and resume daily activities.

  2. Improved quality of life: Successful surgery can significantly enhance a patient's overall quality of life by restoring function and reducing disability.

  3. Increased walking distance: Many patients experience an increased ability to walk longer distances without pain or discomfort after surgery.

  4. Neurological improvement: Surgery can help alleviate neurological deficits caused by nerve compression, improving muscle strength and sensation.

V. Recovery and Rehabilitation

Post-surgery, patients may require a brief hospital stay, followed by a period of rest and rehabilitation. Physical therapy plays a crucial role in strengthening the back and core muscles, improving flexibility, and restoring functional abilities. The recovery timeline varies depending on the surgical procedure, patient's overall health, and individual factors.

Conclusion

Spinal stenosis surgery offers a viable solution for patients who have exhausted non-surgical treatment options. The surgical approaches discussed, such as decompressive laminectomy, laminotomy, foraminotomy, spinal fusion, and interspinous process spacer, aim to relieve nerve compression and restore spinal stability. While surgery carries inherent risks, the potential benefits in terms of symptom relief, improved mobility, and enhanced quality of life make it a valuable treatment option for individuals suffering from spinal stenosis. As with any surgical intervention, patients should consult with their healthcare provider to assess the suitability of surgery based on their unique circumstances.

Cost in India:

The cost of spinal stenosis surgery in India can vary depending on factors such as the hospital, surgeon's fees, location, and specific treatment required. It is recommended to consult with a hospital or healthcare provider for accurate and up-to-date cost information related to spinal stenosis surgery in India.

[pain-management-clinic]

Our Treatments

Here is an abbreviated list of some of the our treatments we perform:

Epidural steroid injection (cervical, thoracic, lumbar, caudal)

Selective nerve root block / transforaminal epidural steroid injections (TFESI)

Radiofrequency neurolysis

Peripheral nerve stimulation

Intrathecal baclofen pain pump

Discography

Vertebroplasty

Spinal cord stimulator

Sympathetic blocks / neurolytics

Facet joint injections

Interspinous spacer placement

Sacroiliac joint injection

Intra-articular, bursal and trigger point injections

Medial branch nerve block

Facet nerve block

Gasserian / sphenopalatine ganglion blocks

Intrathecal opioid pain pump trial/implantation

Kyphoplasty

Joint injection (sacroiliac, hip joint, bursa)

Minimally invasive lumbar discectomy

Nucleoplasty / disc decompression

Intrathecal infusion pump

Lumbar and cervical radiofrequency ablation

Disc decompression

Botulinum toxin neuromuscular injections

Osteopathic manipulative medicine

more: https://www.foothillspainmanagementclinic.com/our-treatments

[shruti240]

Spine Surgery Market Witness the massive growth of the market to 2028 | Aesculap, Inc.

Spine Surgery Market 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟐 𝐢𝐬 𝐜𝐚𝐫𝐞𝐟𝐮𝐥𝐥𝐲 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐧 𝐚 𝐪𝐮𝐚𝐥𝐢𝐭𝐚𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 quantitative 𝐰𝐚𝐲 𝐭𝐨 𝐞𝐧𝐬𝐮𝐫𝐞 𝐚 𝐬𝐮𝐜𝐜𝐞𝐬𝐬𝐟𝐮𝐥 𝐨𝐮𝐭𝐜𝐨𝐦𝐞 of the Spine SurgeryMarket. In addition to identifying, analyzing, and estimating new trends, this research report also examines key industry drivers, challenges, and opportunities in addition to evaluating competitors, geographical areas, types, and applications. Understanding the competitive landscape is crucial for determining the product improvements that are needed. Industries can securely make decisions about their production and marketing strategy since they can obtain comprehensive insights from a Spine Surgeryreport.

𝐀 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐜𝐚𝐧 𝐛𝐞 𝐯𝐢𝐞𝐰𝐞𝐝 𝐛𝐲 𝐯𝐢𝐬𝐢𝐭𝐢𝐧𝐠 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐞𝐌𝐚𝐢𝐥 𝐈𝐃 𝐭𝐨 𝐆𝐞𝐭 𝐇𝐢𝐠𝐡𝐞𝐫 𝐏𝐫𝐢𝐨𝐫𝐢𝐭𝐲) 𝐚𝐭:

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞: Aesculap, Inc., DePuy Synthes, Medtronic, Stryker, Zimmer-Biomet, Abbott Laboratories, Globus Medical Inc., NuVasive, OrthofixInternationalN.V., and RTI Surgicals.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐁𝐲 𝐓𝐲𝐩𝐞

Open Spine Surgery

Minimally Invasive Spine Surgery

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Spinal Fusion Implants

Motion Preservation Devices

Interspinous Process Spacers

Spine Bone Stimulators

Spine Biologics

Bone Graft Substitutes

Cell-Based Matrix

By Region

North America, US, Canada, Latin America, Brazil, Mexico, Rest of Latin America, Western Europe, Germany, UK, France, Spain, Italy, Benelux, Nordic, Rest of Western Europe, Eastern Europe, Russia, Poland, Rest of Eastern Europe, Asia Pacific, China, Japan, India, South Korea, Australia, ASEAN (Indonesia, Vietnam, Malaysia, etc.), Rest of Asia Pacific, Middle East & Africa, GCC, South Africa, Turkey and Rest of the Middle East & Africa.

Key Highlights

• The report provides analysis of current global Spine Surgerymarket landscape.

• The report explores the most likely scenarios of the pandemic that are going to impact the Spine Surgeryindustry in long-term.

• The report does a detailed analysis studying how the global market is changing.

• The report looks at how the global Spine Surgerymarket is shifting, the target market which have biggest opportunities, and trends on horizon that may impact your business directly or indirectly.

• The report highlights the key challenges, risk that you may face in near term as well as highlights opportunities.

Explore Full Report with Detailed TOC Here:

𝐓𝐚𝐛𝐥𝐞 𝐎𝐟 𝐂𝐨𝐧𝐭𝐞𝐧𝐭: 1. Spine SurgeryMarket Introduction 1.1. Definition 1.2. Research Scope 2. Executive Summary 2.1. Key Findings by Major Segments 2.2. Top strategies by Major Players 3. Global Spine SurgeryMarket Overview 3.1. Spine SurgeryMarket Dynamics 3.1.1. Drivers 3.1.2. Opportunities 3.1.3. Restraints 3.1.4. Challenges 3.2. COVID-19 Impact Analysis in Global Spine SurgeryMarket 3.3. PESTLE Analysis 3.4. Opportunity Map Analysis 3.5. PORTER’S Five Forces Analysis 3.6. Market Competition Scenario Analysis 3.7. Product Life Cycle Analysis 3.8. Manufacturer Intensity Map 3.9. Major Companies sales by Value & Volume 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐞.

Complete Growth Report Is Available (Including the Full TOC, Tables and Figures, Graphs as Well As Chart):

About Exactitude Consultancy

Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data. Contact us for your special interest research needs at sales@exactitudeconsultancy.com  and we will get in touch with you within 24hrs and help you find the market research report you need.

Website: https://exactitudeconsultancy.com/

Irfan Tamboli

Contact: +91-7507-07-8687

[crimsonpublishers]

Early Outcome of Discectomy with Interspinous Process Distraction Device a Retrospective Cross-Sectional Study _ Crimson Publishers

Early Outcome of Discectomy with Interspinous Process Distraction Device a Retrospective Cross-Sectional Study by Gunaseelan Ponnusamy* in Crimson Publishers: Peer Reviewed Orthopedic Research Journals 

Objectives: The main aim of this retrospective study was to evaluate the usefulness and early outcome and radiological changes after discectomy with DIAM implant insertion for patients with herniation of nucleus pulposus.

Methods: Thirty-three patients underwent discectomy with DIAM implant insertion for a herniation of nucleus pulposus between June 2009 and April 2014 in Hospital Kuala Lumpur, Malaysia were considered for this study. All datas were collected by reviewing the patient's medical record. All patients had back pain and leg or buttock pain associated with radiological evidence of herniation of nucleus pulpous with failure to 3 months of conservative management. All patients had post-operative follow-up at 2 weeks, 3 months and 6 months after the surgery with documented VAS scores (back and leg pain) and Oswestry Disability Index preoperative and postoperatively. Disc height was measured on the preoperative and postoperative plain radiograph.

Results: 23 male and 10 female were treated. The mean age was 39.82 years old. The most common level was L5/S1 (58%). Preoperative VAS score for leg pain and low back pain improved from 4.3±1.7 and 4.5±1.4 to 1.1±0.8 and 2.2±1.2 respectively at last clinic visit (p<0.001). The average preoperative ODI was 24.6±18.1 and postoperative at 6-month was 12.5±10.2 giving a statistically significant difference (p<0.001) in functional disability outcome. There was no significant in preoperative and postoperative disc height and intervertebral angle at index level.

Conclusion: The early outcome of treatment of low back pain with radiculopathy treated with discectomy and placement of non-fusion DIAM interspinous process spacer showed significant ODI and VAS outcome scores at baseline, 2 weeks, 3 months and at 6 months follow up. There were no significant changes in preoperative and postoperative disc height and intervertebral angle at index level. No adverse local or systemic reaction to the DIAM was noted.

For more Open access journals in Crimson Publishers please click on below link https://crimsonpublishersresearch.com/

For more article in Peer Reviewed Orthopedic Research Journals please click on below link https://crimsonpublishers.com/oproj/

[mi-researchreports]

Interspinous Spacers Market is poised to grow at CAGR of 5 % by 2027. Factors driving  Interspinous Spacers Market are geriatric population is increasing globally and there is an increasing demand for minimally invasive procedures for spinal stenosis.

[jesse-pinkman123]

Interspinous Spacers Market Size, Trends, Shares, Insights and Forecast – 2018-2026

Interspinous Spacers Market, by Product Type (Static (Non-compressible Spacers) and Dynamic (Compressible Spacers), by Indication (Lumbar Spinal Stenosis and Degenerative Disc Diseases), by End User (Hospitals, Ambulatory Surgery Centers, and Orthopedic Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis, 2019-2026

Interspinous spacers, also known as interspinous process decompression systems, are devices implanted between vertebral spinous processes. These spacers are made up of a very strong but lightweight metal (titanium), which is biocompatible in the human body. Lumbar spinal stenosis is a thinning of the spinal canal in the lower back, which causes compression on nerves. The condition develops gradually with age. Radiology tests are used to confirm the diagnosis of moderate degenerative lumbar spinal stenosis. Increasing prevalence of spinal stenosis due to aging and high demand for minimal invasive surgery is expected to drive the interspinous spacers market growth.

Interspinous Spacers Market – Drivers

Increasing product approvals from regulatory bodies is expected to drive the interspinous spacers market growth during the forecast period. For instance, in 2015, the U.S. Food and Drug Administration (FDA) approved Superion InterSpinous Spacer of VertiFlex Inc., VertiFlex Inc. is developer of advanced minimally invasive interventions for spinal stenosis.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2809

Moreover, favorable reimbursement policies is also expected to drive the interspinous spacers market growth during the forecast period. For instance, in 2018, Paradigm Spine, a company specializing in the treatment of lumbar spinal stenosis, announced the issuance of a broad coverage medical policy from BlueCross BlueShield covering its coflex device for the surgical treatment of lumbar spinal stenosis.

Interspinous Spacers Market –Restraints

However, complications associated with lumbar spinal fusion in older patients with spinal stenosis is a major factor restraining the interspinous spacers market growth. For instance, according to the American Association of Neurological Surgeons’ study on complication associated with lumbar spinal stenosis in 2014, 1 in every 6 elderly patients treated with lumbar spinal stenosis underwent reoperation on the spine within two years of surgery and nearly 1 in every 4 patients was readmitted for a surgery-related complication in the US.

Interspinous Spacers Market -Regional Analysis

On the basis of region, the interspinous spacers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the Interspinous Spacers Market over the forecast period, owing to increasing geriatric population with spinal stenosis. For instance, according to American Institute of Minimally Invasive Surgery (AIMIS) 2017 report, around 250,000-500,000 U.S. residents show symptoms of spinal stenosis.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/interspinous-spacers-market-2809

This represents around 1 per 1000 persons older than 65 years and around 5 of every 1000 persons older than 50 years. Around 70 million people in the U.S. are older than 50 years of age.

Asia Pacific is the fastest growing market for interspinous spacers, owing to increasing healthcare expenditure. For instance, according to the Ministry of Health, Labor and Welfare of Japan, US$ 374.12 billion was invested in the healthcare sector in Japan in 2017.

Interspinous Spacers Market -Competitive Landscape

Key players operating in the interspinous spacers market include, Alphatec Spine, Inc., Globus Medical, Inc., Life Spine, Medtronic, Mikai S.p.A, NuVasive, Inc., Paradigm Spine, Synthes GmbH, Vertiflex, Inc., and Zimmer Biomet.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2809

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737